sacral neuromodulation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with an age range of between 18 and 75 years, male or female; (2) Patients with hyperactivity of bladder, non-obstructive urinary retention, pelvic pain or painful bladder syndrome; (3) Patients volunteered to take part in this clinical trial, and signed informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnant women; (2) Body mass index (BMI) greater than 35; (3) Without indications for the operation; (4) With serious system disease in heart, liver,etc. (5) With chronic diseases combined hypertension,diabetes,or coronary heart disease; (6) With poor compliance; (7) Evaluated as being not suitable for this clinical trial; (8) Participated in other clinical trials within a month; (9) Allergic constitution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Times of needle puncturee;Intraoperative control test time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Puncture success time;score of patient's satisfaction;Phase II conversion rate (%); | — |
Countries
China
Contacts
The Second Hospital of Tianjin Medical University